Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates
Mihirbaran Mandal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Haifeng Tang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shu‐Wei Yang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Priya Dayananth(Merck & Co., Inc., Rahway, NJ, USA (United States)), Reynalda K. de Jesus(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hai‐Young Kim(Pfizer (United States)), Donald Chu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Edward DiNunzio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ann E. Weber(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alexander Pasternak(Merck & Co., Inc., Rahway, NJ, USA (United States)), Todd A. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), Katherine Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jianping Pan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jacqueline D. Hicks(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rumin Zhang(Discovery Institute), Artjohn Villafania(Merck & Co., Inc., Rahway, NJ, USA (United States)), Haiqun Tang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Giovanna Scapin, Yuriko Root(Merck & Co., Inc., Rahway, NJ, USA (United States)), Thierry Fischmann(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amy Flattery(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alex G. Therien(Merck Canada Inc. (Canada)), Jim Tata(Merck & Co., Inc., Rahway, NJ, USA (United States)), Todd Mayhood(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alexei V. Buevich(Merck & Co., Inc., Rahway, NJ, USA (United States)), Emma R. Parmee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles G. Garlisi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Winnie Prosise(Merck & Co., Inc., Rahway, NJ, USA (United States)), Guoqing Li(Zhejiang Chinese Medical University), Li Xiao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jing Su(Merck & Co., Inc., Rahway, NJ, USA (United States)), Daniel F. Wyss, Weidong Pan(Guiyang Medical University), Carrie G. Markgraf(Merck & Co., Inc., Rahway, NJ, USA (United States)), Christine Yang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lianzhu Liang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Asra Mirza(Merck & Co., Inc., Rahway, NJ, USA (United States)), Payal R. Sheth(Merck & Co., Inc., Rahway, NJ, USA (United States)), Inhou Chu, Jin Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ronald E. Painter(Merck & Co., Inc., Rahway, NJ, USA (United States)), William K. Hagmann(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shuzhi Dong(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 27
Related Papers
A Draft Sequence for the Genome of the Domesticated Silkworm ( <i>Bombyx mori</i> )
|Science|2004|1.2k
The diploid genome sequence of an Asian individual
|Nature|2008|960
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
A geminivirus-related DNA mycovirus that confers hypovirulence to a plant pathogenic fungus
|Proceedings of the National Academy of Sciences|2010|563